APOE Promoter Polymorphism-219T/G is an Effect Modifier of the Influence of APOE ε4 on Alzheimer’s Disease Risk in a Multiracial SampleKyu Choi, Gyungah Jun, Jungsoo Gim et al.|Journal of Clinical Medicine|2019Cited by 76
Anti-fibrotic activity of a rho-kinase inhibitor restores outflow function and intraocular pressure homeostasisGuorong Li, W. Daniel Stamer, Chan-Young Lee et al.|eLife|2021Cited by 66
Cerebrospinal Fluid Biomarkers for the Diagnosis of Prodromal Alzheimer’s Disease in Amnestic Mild Cognitive ImpairmentJung Eun Park, Kun Ho Lee, Kyu Yeong Choi et al.|Dementia and Geriatric Cognitive Disorders Extra|2019Cited by 35
Comparison of Two Analytical Platforms in Cerebrospinal Fluid Biomarkers for the Classification of Alzheimer’s Disease Spectrum with Amyloid PET ImagingHo Jae Lim, Kun Ho Lee, Jung Eun Park et al.|Journal of Alzheimer s Disease|2020Cited by 12
Can hippocampal subfield measures supply information that could be used to improve the diagnosis of Alzheimer’s disease?Balaji Kannappan, Kun Ho Lee, Yu Yong Choi et al.|PLoS ONE|2022Cited by 7